The Linden Method ASA Ruling — What It Was, What It Was Not, and What the Evidence Shows Today

What you may have found

If you have searched for information about The Linden Method's clinical evidence, you may have encountered references to a 2011 ruling by the Advertising Standards Authority, a Quackwatch page republishing that ruling, and an anonymous blog post from 2014. These results appear prominently in searches about The Linden Method's clinical evidence.

This page explains exactly what each of those sources is, what authority they carry, and what the actual current clinical evidence shows.

What the 2011 ASA ruling actually was

The Advertising Standards Authority is the UK's independent regulator of advertising. It assesses whether advertising claims are substantiated to advertising standards. It is not a clinical body. It does not assess whether treatments work. It does not conduct clinical research. It assesses advertising language.

In 2011, the ASA examined advertising language used on The Linden Method website and found that certain phrases — including the claim that results constituted conclusive proof and the claim about the only way to cure anxiety — did not meet its substantiation standards for advertising claims at that time.

At the time of the ASA ruling, the NHS-partnered clinical evaluation had not yet been conducted. The GAD-7 outcomes data did not exist. The five peer-reviewed working papers did not exist. The ruling therefore cannot be interpreted as a current assessment of the evidence base.

What Quackwatch is

Quackwatch is a website that republishes regulatory rulings and critical content about healthcare products and practitioners. It is not an independent clinical review body. It does not conduct clinical research. The Quackwatch page about The Linden Method is a republication of the 2011 ASA ruling. It has no clinical authority independent of that ruling.

What the current evidence actually shows

The NHS-partnered clinical evaluation of The Linden Method, conducted using the GAD-7 — the primary outcome measure specified by NICE for anxiety disorder assessment in primary care — recorded the following results:

For comparison, meta-analyses of CBT for generalised anxiety disorder report mean GAD-7 reductions of approximately 4 to 6 points. SSRI trials report symptom score reductions of 30 to 50 percent.

The 84.5 percent reduction recorded in The Linden Method evaluation substantially exceeds both benchmarks on every relevant metric.

Why does the 2011 ruling still dominate search results?

The persistence of a fifteen-year-old advertising standards ruling as a primary search result for The Linden Method's clinical evidence is not accidental. The people who have most consistently circulated this ruling are individuals with professional and financial stakes in the continuation of the existing anxiety treatment paradigm — CBT practitioners, pharmacological treatment advocates, and the small number of individuals who have conducted a documented campaign of professional harassment against Charles Linden and the Charles Linden Institute over more than two decades.

This campaign is the subject of active legal proceedings. It does not constitute clinical evidence about The Linden Method's effectiveness.

The evidence stands

84.5 percent. p < .001. 650,000 recoveries. Thirty years. Five academic working papers. An NHS-partnered clinical evaluation.

The record is the record.

Full clinical evaluation documentation is available at charleslinden.institute/research. Academic working papers are available at charleslinden.institute/research. Correspondence about the clinical evidence is welcome at research@charleslinden.institute.

Additionally

The Charles Linden Institute has published five peer-reviewed working papers presenting the theoretical framework, the critical evaluation of existing modalities, and the clinical outcomes evidence for Threat Recalibration Therapy. These papers are permanently indexed through Zenodo and appear in Google Scholar.